Cholinergic pharmacology
Drugs that mimic, enhance or block acetylcholine: muscarinic agonists and antagonists, anticholinesterases including organophosphates, and the anticholinergic and cholinergic toxidromes.
By the end of this page you should be able to
- Classify cholinergic receptors and the drugs acting on them.
- Describe the pharmacology of atropine and glycopyrrolate and compare tertiary and quaternary antimuscarinics.
- Classify anticholinesterases and describe the uses and adverse effects of neostigmine.
- Describe organophosphate poisoning, including ageing, and its treatment.
- Recognise the anticholinergic toxidrome and list common causative drugs.
Receptors and the drugs that act on them
- Muscarinic (M1 to M5): G protein-coupled. M1 neural and gastric, M2 cardiac (Gi), M3 smooth muscle, glands and endothelium (Gq). Agonists: pilocarpine (glaucoma, dry mouth), bethanechol. Antagonists: atropine, glycopyrrolate, hyoscine, ipratropium and tiotropium, benztropine.
- Nicotinic, muscle type (Nm): ligand-gated channels at the neuromuscular junction. Blocked by neuromuscular blockers; activated by suxamethonium.
- Nicotinic, neuronal type (Nn): autonomic ganglia, adrenal medulla, CNS. Nicotine stimulates then blocks; ganglion blockers (historic: trimetaphan) block both divisions at once.
- Indirect agonists: anticholinesterases raise ACh at every cholinergic synapse.
Antimuscarinics: atropine and friends
Atropine is a naturally occurring tertiary amine (from deadly nightshade), a competitive antagonist at all muscarinic subtypes. Being tertiary, it crosses the blood-brain barrier and the placenta. Uses: symptomatic bradycardia, organophosphate and carbamate poisoning, drying secretions, with neostigmine at reversal, and as a mydriatic. Small doses can paradoxically slow the heart briefly (central vagal stimulation or presynaptic M1 block).
Glycopyrrolate is a quaternary amine: permanently charged, so it does not cross the blood-brain barrier or placenta. It dries secretions with less tachycardia and no central effects; slower onset than atropine. Hyoscine (scopolamine) is tertiary and strongly central: sedation, amnesia and antiemesis (motion sickness); hyoscine butylbromide is quaternary and used as a gut antispasmodic. Ipratropium is a quaternary inhaled bronchodilator. Benztropine is a centrally acting antimuscarinic used for acute dystonia.
The effects of muscarinic blockade, from the lowest dose: dry mouth and reduced sweating, then mydriasis and tachycardia, then urinary retention and reduced gut motility, then central effects.
Anticholinesterases
- Short-acting (reversible, binds by electrostatic attraction): edrophonium, formerly used to diagnose myasthenia.
- Medium (carbamates, carbamylate the enzyme, hydrolysed over hours): neostigmine and pyridostigmine (quaternary: no CNS effect); physostigmine (tertiary: crosses into the CNS, used for central anticholinergic toxicity); rivastigmine and donepezil (dementia).
- Irreversible (organophosphates, phosphorylate the enzyme): insecticides (chlorpyrifos, dimethoate), nerve agents (sarin, VX), and echothiophate.
- Neostigmine reverses non-depolarising neuromuscular block by raising ACh to outcompete the blocker. It needs some spontaneous recovery first and has a ceiling: once acetylcholinesterase is fully inhibited, more neostigmine adds nothing, and an excess can itself cause depolarising weakness. It is always given with glycopyrrolate or atropine to block its muscarinic effects (bradycardia, bronchospasm, secretions, gut hyperactivity). It prolongs suxamethonium block by also inhibiting plasma cholinesterase.
- Pyridostigmine is the oral mainstay in myasthenia gravis. Too much causes a cholinergic crisis with weakness that looks like a myasthenic crisis.
Organophosphate poisoning
Organophosphates are absorbed through skin, lungs and gut and phosphorylate the serine at the active site of acetylcholinesterase (and plasma cholinesterase). Over time the phosphorylated enzyme loses an alkyl group (ageing), after which it can no longer be reactivated; ageing takes minutes for some nerve agents and hours to days for pesticides.
Features reflect excess ACh at all sites:
- Muscarinic: the killer is the chest: bronchorrhoea and bronchospasm, with bradycardia, salivation, lacrimation, urination, diarrhoea, vomiting and miosis.
- Nicotinic: fasciculations then weakness and paralysis (including respiratory muscles); tachycardia and hypertension from ganglionic stimulation can mask the bradycardia.
- Central: agitation, confusion, seizures, coma, central respiratory depression.
- Intermediate syndrome: proximal, neck flexor, cranial nerve and respiratory weakness 1 to 4 days later, after the cholinergic crisis has settled; can cause late respiratory failure.
- Delayed polyneuropathy: weeks later, distal sensorimotor (inhibition of neuropathy target esterase).
- Treatment: decontaminate (remove clothes, wash skin, staff protection), oxygen and airway, atropine in escalating doses (doubling) until the chest is dry, heart rate above 80 and systolic pressure above 80, then infusion; benzodiazepines for seizures. Pralidoxime (an oxime) reactivates the enzyme before ageing, but evidence for benefit in pesticide poisoning is weak. Avoid suxamethonium (prolonged paralysis).
The anticholinergic toxidrome
"Hot as a hare, dry as a bone, red as a beet, blind as a bat, mad as a hatter, full as a flask": hyperthermia, dry skin and mouth, flushing, mydriasis with blurred vision, agitated delirium with picking movements, urinary retention, absent bowel sounds and tachycardia. Sweating is absent, which separates it from sympathomimetic toxicity.
Causes include antihistamines (promethazine, diphenhydramine, doxylamine), tricyclic antidepressants, antipsychotics (olanzapine, quetiapine), benztropine, hyoscine, and plants such as Datura (angel's trumpet). Management is supportive: benzodiazepines for agitation, cooling, catheterisation for retention, and in selected cases physostigmine for severe central toxicity, avoided when a tricyclic or a wide QRS is present.
Making the answer flow
- Classify first: direct agonists, antagonists, indirect agonists. Then pick one drug from each and describe it fully.
- The tertiary versus quaternary distinction explains almost every difference between atropine, glycopyrrolate, hyoscine, physostigmine and neostigmine.
- For organophosphates, say the treatment endpoint: a dry chest, not a dilated pupil or a heart rate.
Where marks are lost
- Titrating atropine to pupil size in organophosphate poisoning.
- Saying neostigmine crosses the blood-brain barrier. It is quaternary; physostigmine is the one that does.
- Forgetting that neostigmine has a ceiling effect and needs some spontaneous recovery first.
- Saying atropine reverses the weakness of organophosphate poisoning. It acts at muscarinic receptors only.
Where this meets anaesthesia
- Neostigmine increases acetylcholine at muscarinic as well as nicotinic sites, so it is given with glycopyrrolate or atropine.
- Glycopyrrolate is a quaternary amine that does not cross the blood-brain barrier; atropine does, and can cause central anticholinergic effects.
Viva questions
Answer each one aloud, as you would to an examiner, before you open the model points.
- 1.
Compare atropine and glycopyrrolate.
Show answer
- Both competitive muscarinic antagonists.
- Atropine: tertiary, crosses BBB and placenta, faster onset, more tachycardia, central effects (confusion in the elderly), shorter action.
- Glycopyrrolate: quaternary, no CNS or placental transfer, slower onset, better antisialagogue relative to heart rate effects, longer action.
- Choice: atropine for urgent bradycardia and organophosphates; glycopyrrolate with neostigmine and for secretions.
- 2.
A farmer is brought in drooling, wheezing, bradycardic and twitching. Explain the pathophysiology and management.
Show answer
- Organophosphate inhibition of acetylcholinesterase; excess ACh at muscarinic, nicotinic and central synapses.
- Muscarinic: bronchorrhoea, bronchospasm, bradycardia, miosis, SLUDGE. Nicotinic: fasciculation, weakness. Central: seizures, coma.
- Staff protection and decontamination; airway and oxygen; atropine doubling doses until chest clear, HR and BP targets met, then infusion; benzodiazepines for seizures.
- Avoid suxamethonium; consider pralidoxime; watch for intermediate syndrome.
- 3.
What is ageing of acetylcholinesterase?
Show answer
- After organophosphate phosphorylation of the active site serine, loss of an alkyl group strengthens the bond.
- Aged enzyme cannot be reactivated by oximes; recovery needs synthesis of new enzyme (weeks).
- Time to ageing varies: minutes for soman, hours for many pesticides.
- Therefore oximes, if used, must be given early.
- 4.
Describe the pharmacology of neostigmine.
Show answer
- Quaternary carbamate anticholinesterase; carbamylates the enzyme, hydrolysed over hours (reversible).
- IV onset several minutes, peak about 7 to 10 minutes; renal excretion (prolonged in renal failure).
- Uses: reversal of non-depolarising block, myasthenia, urinary retention, colonic pseudo-obstruction.
- Muscarinic adverse effects (bradycardia, bronchospasm, secretions, nausea) countered by glycopyrrolate; ceiling effect; can prolong suxamethonium; can cause weakness in excess.
- 5.
Describe the anticholinergic toxidrome and its causes.
Show answer
- Peripheral: tachycardia, dry flushed skin, hyperthermia, mydriasis, urinary retention, reduced bowel sounds.
- Central: agitated delirium, hallucinations, picking behaviour, seizures, coma.
- Causes: antihistamines, tricyclics, antipsychotics, benztropine, hyoscine, Datura.
- Management: supportive, benzodiazepines, cooling, catheter; physostigmine in selected severe central toxicity without QRS widening.
- 6.
What is the difference between a myasthenic crisis and a cholinergic crisis?
Show answer
- Myasthenic: worsening disease (infection, surgery, drugs such as aminoglycosides, magnesium, beta blockers) with too little effective ACh transmission.
- Cholinergic: excess anticholinesterase causing depolarising block, with muscarinic signs (miosis, sweating, salivation, bradycardia, diarrhoea).
- Both cause weakness and respiratory failure; secure the airway first, then distinguish.
- Edrophonium was once used to tell them apart; now withhold anticholinesterases, ventilate, and treat the cause.
- 7.
Why is atropine sometimes ineffective for bradycardia?
Show answer
- Works only if bradycardia is vagally mediated or depends on AV nodal conduction.
- Ineffective in the denervated transplanted heart (no vagal input).
- Often ineffective in infranodal (Mobitz II, complete heart block with wide escape) block.
- Ineffective in beta blocker or calcium channel blocker toxicity and hyperkalaemia where the problem is not vagal.
- Alternatives: adrenaline or isoprenaline infusion, pacing.
- 8.
Which antimuscarinic drugs cross the blood-brain barrier, and why does it matter?
Show answer
- Tertiary amines (atropine, hyoscine hydrobromide, benztropine) cross; quaternary amines (glycopyrrolate, ipratropium, hyoscine butylbromide) do not.
- Central effects: sedation, amnesia, delirium (especially elderly), antiemesis, antiparkinsonian effect.
- Physostigmine (tertiary anticholinesterase) reverses central anticholinergic syndrome; neostigmine does not.
- 9.
Explain the actions of nicotine.
Show answer
- Agonist at neuronal nicotinic receptors: autonomic ganglia, adrenal medulla, CNS reward pathways (dopamine release).
- Low doses stimulate sympathetic and parasympathetic ganglia: tachycardia, hypertension, nausea, salivation.
- High doses (poisoning, e.g. e-cigarette liquid in children): initial stimulation then depolarising ganglionic and neuromuscular block, seizures, respiratory failure.
Practise this week
- Primary MCQs: pharmacology
- Primary SAQs, marked part by part
- Primary vivas
- Viva Examiner: practise answering aloud
Week 7 in the other subjects
- Physiology: Autonomic nervous system and pain
Not affiliated with the Australian and New Zealand College of Anaesthetists (ANZCA). Notes are a revision aid, not a substitute for the curriculum or for clinical guidelines.